Microbial pathogens are the most prevalent cause of chronic infections and fatalities around
the world. Antimicrobial agents including antibiotics have been frequently utilized in the …

The first marketed example of the application of microcapsules dates back to 1957. Since
then, microencapsulation techniques and knowledge have progressed in a plethora of …

Burkholderia cenocepacia is an opportunistic pathogen particularly dangerous for cystic
fibrosis (CF) patients. It can cause a severe decline in CF lung function possibly develo** …

Fighting of current antibiotics against multidrug-resistant (MDR) bacteria has not been
completely successful. In this study, the bio-synthesized Ag–TiO2, TiO2–Ag, Ag–Cu and Cu …

There is a global epidemic of non-healing wounds. Chronic inflammation, overexpression of
pro-inflammatory cytokines, oxidative stress and bacterial infection are implicated in delayed …

The encapsulation of biologically active ingredients (eg, peptides, proteins, enzymes, drugs)
into polymer particles is extensively used for drug delivery purposes. However, this strategy …

Multifunctional nanotheranostic platforms are emerging for the treatment of bacterial
infections. Uncontrollable drug release and poor response in target location leads to …

Cystic fibrosis (CF) patients are at particular risk of infection by microorganisms that are
resistant to several antibiotics. About 3% of CF patients are colonized by Burkholderia …

The use of lipid nanoparticles as drug delivery systems has been growing over recent
decades. Their biodegradable and biocompatible profile, capacity to prevent chemical …

Plant-derived aldehydes are constituents of essential oils that possess broad-spectrum
antimicrobial activity and kill microorganisms without promoting resistance. In our previous …